Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of testosterone on bone turnover markers in transgender male
TCTR20220817002Unknown
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone in gender dysphoria (GD), sponsored by King Chulalongkorn Memorial Hospital. Primary endpoint: Change in bone turnover markers. Status: unknown.
02
Drugs
testosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on TCTR20220817002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220817002.